NCT01933516View on ClinicalTrials.gov

GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Indolent B-cell Non-Hodgkin's Lymphoma

Interventions

DRUG

GP2013

GP2013

Trial Locations (1)

190-0014

Investigative Site, Tachikawa

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Sandoz

INDUSTRY